{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:41:08Z","timestamp":1792708868660,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Kidney Foundation Netherlands","doi-asserted-by":"publisher","award":["20OK014"],"award-info":[{"award-number":["20OK014"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Kidney Foundation Netherlands","doi-asserted-by":"publisher","award":["17PhD02"],"award-info":[{"award-number":["17PhD02"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bbamcr.2026.120211","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:50:24Z","timestamp":1787669424000},"page":"120211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeted analysis of salicylate binding partners in renal epithelial cells reveals major AMPK dependency"],"prefix":"10.1016","volume":"1873","author":[{"given":"Anish A.","family":"Kanhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Lodder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisanne E.","family":"Wisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Louzao-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Bange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo S.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter N.","family":"Leonhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2026.120211_bb0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","volume":"77","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0015","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","article-title":"PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein","volume":"272","author":"Mochizuki","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109648","article-title":"Molecular pathways involved in injury-repair and ADPKD progression","volume":"72","author":"Formica","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0030","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0035","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0040","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-3-319-51436-9_12","article-title":"Inflammation and fibrosis in polycystic kidney disease","volume":"60","author":"Song","year":"2017","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0050","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1091\/mbc.e16-08-0597","article-title":"The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function","volume":"28","author":"Padovano","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0065","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-Deoxy-d-glucose ameliorates PKD progression","volume":"27","author":"Chiaravalli","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0070","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease","volume":"27","author":"Warner","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0075","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease","volume":"310","author":"Kipp","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0080","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1038\/ncomms14395","article-title":"MicroRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.09.012","article-title":"Ketosis ameliorates renal cyst growth in polycystic kidney disease","volume":"30","author":"Torres","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ebiom.2019.08.041","article-title":"Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease","volume":"47","author":"Leonhard","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.1001941","article-title":"Beneficial effects of bempedoic acid treatment in polycystic kidney disease cells and mice","volume":"9","author":"Hallows","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1058825","article-title":"Preclinical evaluation of tolvaptan and salsalate combination therapy in a Pkd1-mouse model","volume":"10","author":"Song","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.kint.2023.01.026","article-title":"A novel direct adenosine monophosphate kinase activator ameliorates disease progression in preclinical models of Autosomal Dominant Polycystic Kidney Disease","volume":"103","author":"Dagorn","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070806","article-title":"HL156A, an AMP-activated protein kinase activator, inhibits cyst growth in autosomal dominant polycystic kidney disease","volume":"14","author":"Seo","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0115","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in health and disease","volume":"89","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0125","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bph.14558","article-title":"The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease","volume":"176","author":"Lian","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0135","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1152\/ajprenal.00298.2021","article-title":"Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model","volume":"322","author":"Pastor-Soler","year":"2022","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108278","article-title":"Short salsalate administration affects cell proliferation, metabolism, and inflammation in polycystic kidney disease","volume":"26","author":"Kanhai","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01828-9","article-title":"Anti-inflammatory effects of aspirin and sodium salicylate","volume":"447","author":"Amann","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0150","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1215327","article-title":"The ancient drug salicylate directly activates AMP-activated protein kinase","volume":"336","author":"Hawley","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fimmu.2016.00206","article-title":"Multiple targets of salicylic acid and its derivatives in plants and animals","volume":"7","author":"Klessig","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0160","doi-asserted-by":"crossref","first-page":"F1193","DOI":"10.1152\/ajprenal.00419.2010","article-title":"Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model","volume":"300","author":"Leonhard","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0165","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00018-017-2460-x","article-title":"Fluid shear stress-induced TGF-\u03b2\/ALK5 signaling in renal epithelial cells is modulated by MEK1\/2","volume":"74","author":"Kunnen","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0170","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1177\/2472555217716056","article-title":"High-throughput phenotypic screening of kinase inhibitors to identify drug targets for polycystic kidney disease","volume":"22","author":"Booij","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0175","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2013.02.012","article-title":"Heme levels are increased in human failing hearts","volume":"61","author":"Khechaduri","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2015-08-663245","article-title":"Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease","volume":"127","author":"Vinchi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.11156","article-title":"Salicylate, diflunisal and their metabolites inhibit CBP\/p300 and exhibit anticancer activity","volume":"5","author":"Shirakawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0190","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1101\/gad.311027.117","article-title":"Acetyl-CoA promotes glioblastoma cell adhesion and migration through Ca(2+)-NFAT signaling","volume":"32","author":"Lee","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000981","article-title":"Acetylation-mediated remodeling of the nucleolus regulates cellular acetyl-CoA responses","volume":"18","author":"Houston","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)01006-4","article-title":"Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase","volume":"353","author":"Sullivan","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0205","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.str.2014.06.009","article-title":"Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms","volume":"22","author":"Calabrese","year":"2014","journal-title":"Structure"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0210","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.2337\/db16-0564","article-title":"Salsalate (salicylate) uncouples mitochondria, improves glucose homeostasis, and reduces liver lipids independent of AMPK-\u03b21","volume":"65","author":"Smith","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0220","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s42003-018-0200-x","article-title":"Dissection of metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways","volume":"1","author":"Podrini","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1050-1738(01)00133-5","article-title":"Salicylates and vascular smooth muscle cell proliferation: molecular mechanisms for cell cycle arrest","volume":"11","author":"Marra","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1113\/jphysiol.2005.100586","article-title":"Cell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylate","volume":"571","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pros.23755","article-title":"Salicylate enhances the response of prostate cancer to radiotherapy","volume":"79","author":"Broadfield","year":"2019","journal-title":"Prostate"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101321","article-title":"Salsalate reduces atherosclerosis through AMPK\u03b21 in mice","volume":"53","author":"Day","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0245","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3892\/ijo.2017.4167","article-title":"Salicylic acid metabolites and derivatives inhibit CDK activity: novel insights into aspirin\u2019s chemopreventive effects against colorectal cancer","volume":"51","author":"Dachineni","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0250","first-page":"20","article-title":"Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: implications in colorectal cancer prevention","volume":"21","author":"Sankaranarayanan","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0255","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0265","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncb3113","article-title":"AMPK modulates hippo pathway activity to regulate energy homeostasis","volume":"17","author":"Wang","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0270","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0275","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.156.10.3961","article-title":"Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration","volume":"156","author":"Pierce","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0285","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cmet.2006.11.005","article-title":"Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling","volume":"4","author":"Steinberg","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0290","doi-asserted-by":"crossref","first-page":"8633","DOI":"10.4049\/jimmunol.181.12.8633","article-title":"Adenosine 5\u2032-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype","volume":"181","author":"Sag","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0295","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1172\/JCI58577","article-title":"Hematopoietic AMPK \u03b21 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity","volume":"121","author":"Galic","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0300","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cmet.2013.06.017","article-title":"AMPK\u03b11 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration","volume":"18","author":"Mounier","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0305","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2337\/db15-0917","article-title":"Myeloid deletion of \u03b11AMPK exacerbates atherosclerosis in LDL receptor knockout (LDLRKO) mice","volume":"65","author":"Cao","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0310","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood.V11.9.821.821","article-title":"Studies on the biosynthesis of heme in vitro by avian erythrocytes","volume":"11","author":"Ashenbrucker","year":"1956","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0315","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0003-9861(56)90273-9","article-title":"Formation of heme by broken-cell preparations of duck erythrocytes","volume":"64","author":"Klein","year":"1956","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0320","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1124\/mol.113.087940","article-title":"Salicylic acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity","volume":"84","author":"Gupta","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0325","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.4049\/jimmunol.163.10.5608","article-title":"Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-dependent transcription of cyclic AMP response element binding protein- and NF-kappa B-responsive genes","volume":"163","author":"Stevenson","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0330","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0335","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2010-1816","article-title":"Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions","volume":"96","author":"Meex","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0340","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.2042-7158.1968.tb09619.x","article-title":"The distribution of salicylate in mouse tissues after intraperitoneal injection","volume":"20","author":"Sturman","year":"1968","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0345","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.2042-7158.1970.tb08442.x","article-title":"The relation between circulating and tissue concentrations of salicylate in the mouse in vivo","volume":"22","author":"McArthur","year":"1970","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0350","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3565(25)20874-6","article-title":"Renal handling of salicyluric acid in the isolated perfused rat kidney: evidence for accumulation in tubular cells","volume":"251","author":"Cox","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0355","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-3565(25)28875-9","article-title":"On the mechanisms of 14C-salicylic acid distribution in rat submaxillary gland in vitro","volume":"177","author":"Putney","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0360","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1056\/NEJMra2010852","article-title":"Salicylate toxicity","volume":"382","author":"Palmer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0365","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ki.2013.399","article-title":"Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport","volume":"85","author":"Yeung","year":"2014","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0370","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ackd.2015.10.002","article-title":"The effects of CKD on cytochrome P450-mediated drug metabolism","volume":"23","author":"Ladda","year":"2016","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0375","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2215\/CJN.00340118","article-title":"Clinical pharmacokinetics in kidney disease: fundamental principles","volume":"13","author":"Lea-Henry","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0380","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cpt.3715","article-title":"Changes in protein expression of renal drug transporters and drug-metabolizing enzymes in autosomal dominant polycystic kidney disease patients","volume":"118","author":"Tillmann","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0385","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/17425255.2025.2501127","article-title":"Pharmacotherapy in kidney disease: what it takes to move from general guidance to specific recommendations to stratified subgroups of patients - the tale of autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Tillmann","year":"2025","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI16567","article-title":"The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity","volume":"111","author":"Viollet","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0395","doi-asserted-by":"crossref","first-page":"H2875","DOI":"10.1152\/ajpheart.01032.2005","article-title":"Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia","volume":"291","author":"Zarrinpashneh","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0400","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1152\/ajpendo.00243.2006","article-title":"Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle","volume":"292","author":"J\u00f8rgensen","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0405","doi-asserted-by":"crossref","first-page":"H3136","DOI":"10.1152\/ajpheart.00683.2006","article-title":"Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion","volume":"292","author":"Carvajal","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0410","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1042\/bj0970194","article-title":"Effect of salicylate on oxidative phosphorylation and respiration of mitochondrial fragments","volume":"97","author":"Miyahara","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0415","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0006-2952(85)90774-9","article-title":"Salicylate-induced loose coupling: protonmotive force measurements","volume":"34","author":"Haas","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0420","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ebiom.2017.08.004","article-title":"Salsalate activates skeletal muscle thermogenesis and protects mice from high-fat diet induced metabolic dysfunction","volume":"23","author":"Nie","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0425","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0430","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0435","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine","year":"2008","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0440","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13287-023-03554-7","article-title":"AMPK activator-treated human cardiac spheres enhance maturation and enable pathological modeling","volume":"14","author":"Li","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0445","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/febs.70006","article-title":"Activating AMPK improves pathological phenotypes due to mtDNA depletion","volume":"292","author":"Carvalho","year":"2025","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0450","article-title":"AMPK repositions early endosomes via Gapex-5 to promote delivery of iron to mitochondria","author":"Mehrabi","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0455","doi-asserted-by":"crossref","first-page":"C1554","DOI":"10.1152\/ajpcell.00010.2009","article-title":"AMP-activated protein kinase activator A-769662 is an inhibitor of the Na(+)-K(+)-ATPase","volume":"297","author":"Benziane","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0460","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-012-2819-3","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","volume":"56","author":"Goldfine","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0465","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/db14-1125","article-title":"Salsalate activates brown adipose tissue in mice","volume":"64","author":"van Dam","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0470","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12630-021-01935-1","article-title":"Sevoflurane-induced hyperglycemia is attenuated by salsalate in obese insulin-resistant mice","volume":"68","author":"Desjardins","year":"2021","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0475","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0480","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109649","article-title":"Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling","volume":"72","author":"Sussman","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0490","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/j.1460-2075.1992.tb05493.x","article-title":"Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15","volume":"11","author":"Gu","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0495","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/s41416-023-02468-8","article-title":"The cyclin-dependent kinase 1: more than a cell cycle regulator","volume":"129","author":"Massacci","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0500","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/emmm.201302734","article-title":"A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis","volume":"6","author":"Zadra","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0505","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/BJ20150122","article-title":"Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis","volume":"469","author":"O\u2019Brien","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002309","article-title":"Metformin antagonizes cancer cell proliferation by suppressing mitochondrial-dependent biosynthesis","volume":"13","author":"Griss","year":"2015","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0515","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.molmet.2016.08.014","article-title":"The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration","volume":"5","author":"Villani","year":"2016","journal-title":"Mol. Metab."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0520","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5527\/wjn.v5.i4.339","article-title":"Constitutive renal Rel\/nuclear factor-\u03baB expression in Lewis polycystic kidney disease rats","volume":"5","author":"Ta","year":"2016","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0525","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.bcp.2010.08.009","article-title":"AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis","volume":"80","author":"Bai","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108269","article-title":"Macrophage AMPK \u03b21 activation by PF-06409577 reduces the inflammatory response, cholesterol synthesis, and atherosclerosis in mice","volume":"26","author":"Day","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0535","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1186\/s12967-023-04772-6","article-title":"The role of AMPK in macrophage metabolism, function and polarisation","volume":"21","author":"Cui","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0540","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2215\/CJN.05850518","article-title":"Vascular dysfunction, oxidative stress, and inflammation in autosomal dominant polycystic kidney disease","volume":"13","author":"Nowak","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0545","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba3613","article-title":"Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease","volume":"12","author":"Lu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0550","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2317344121","article-title":"A synthetic agent ameliorates polycystic kidney disease by promoting apoptosis of cystic cells through increased oxidative stress","volume":"121","author":"Fedeles","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0555","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1681\/ASN.2011050442","article-title":"Kidney injury accelerates cystogenesis via pathways modulated by heme oxygenase and complement","volume":"23","author":"Zhou","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0560","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fphar.2014.00061","article-title":"Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes","volume":"5","author":"Chiabrando","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0565","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bbamcr.2006.05.005","article-title":"Biosynthesis of heme in mammals","volume":"1763","author":"Ajioka","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0570","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of hepatic 2D Sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0575","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1016\/j.biomaterials.2012.03.001","article-title":"Comparing predictive drug nephrotoxicity biomarkers in kidney 3-D primary organoid culture and immortalized cell lines","volume":"33","author":"Astashkina","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0580","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1038\/s41598-018-22073-7","article-title":"Metabolic characterization of directly reprogrammed renal tubular epithelial cells (iRECs)","volume":"8","author":"Lagies","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2026.120211_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.046","article-title":"Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles","volume":"51","author":"Malas","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbamcr.2026.120211_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1397864","article-title":"Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease","volume":"15","author":"Brownjohn","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488926001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:32:08Z","timestamp":1792708328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488926001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":118,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0167488926001102"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120211","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted analysis of salicylate binding partners in renal epithelial cells reveals major AMPK dependency","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2026.120211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120211"}}